Showing results (161-170 of 194) with videos related to
Sort By:
Pageof 20
Journal of Neurology|February 19, 2014
A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosisT L Vollmer, P S Sorensen, K Selmaj, et al.Journal of Neuroimmunology|November 27, 2009
Dysregulated Epstein-Barr virus infection in patients with CIDPJ D Lünemann, B Tackenberg, A Stein, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 2011
Fatigue in multiple sclerosis is closely related to sleep disorders: a polysomnographic cross-sectional studyC Veauthier, H Radbruch, G Gaede, et al.Journal of Neural Transmission. Supplementum|August 30, 2003
Self-tolerance in the immune privileged CNS: lessons from the entorhinal cortex lesion modelE Kwidzinski, L K Mutlu, A D Kovac, et al.European Journal of Immunology|February 1, 1993
Human T cell autoimmunity against myelin basic protein: CD4+ cells recognizing epitopes of the T cell receptor beta chain from a myelin basic protein-specific T cell cloneG Saruhan-Direskeneli, F Weber, E Meinl, et al.Neurology|April 6, 2011
Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MSM C Kowarik, H L Pellkofer, S Cepok, et al.European Journal of Neurology|October 26, 2005
Guidelines on use of anti-IFN-beta antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN-beta antibodies in multiple sclerosisP S Sørensen, F Deisenhammer, P Duda, et al.Proceedings of the National Academy of Sciences of the United States of America|December 1, 1993
Transformation of human T-cell clones by Herpesvirus saimiri: intact antigen recognition by autonomously growing myelin basic protein-specific T cellsF Weber, E Meinl, K Drexler, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|February 17, 2012
Familial Mediterranean fever-associated mutation pyrin E148Q as a potential risk factor for multiple sclerosisT Kümpfel, L-A Gerdes, T Wacker, et al.Neurology|November 30, 2006
Blockade of chemokine signaling in patients with multiple sclerosisF Zipp, H P Hartung, J Hillert, et al.Pageof 20